AULOS BIOSCIENCE
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Their initial clinical candidate, AU-007, stands apart from existing IL-2 therapeutics by introducing a novel approach that addresses a significant medical challenge of the present era: the eradication of cancer. Through harnessing the anti-cancer potential of interleukin-2, they are breaking down barriers in the field of immuno-oncology. Their distinctive immunotherapy, computationally designed to precisely guide the immune system in attacking tumor cells, is poised to make a substantial impact.
AULOS BIOSCIENCE
Industry:
Biotechnology Health Care Life Science Medical Oncology Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aulosbio.com
Total Employee:
11+
Status:
Active
Contact:
(617) 294-6790
Total Funding:
60 M USD
Technology used in webpage:
Euro Amazon 123FormBuilder
Similar Organizations
Actym Therapeutics, Inc.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Medicenna Therapeutics
Medicenna is a clinical stage, privately held, immuno-oncology company.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Board_member
Board_member
2021-01-01
Board_member
2021-01-01
Current Employees Featured
Micah Pearlman Chief Operating Officer and Co-Founder @ Aulos Bioscience
Chief Operating Officer and Co-Founder
2020-10-01
Michael Ehlers Co-Founder and Executive Chair @ Aulos Bioscience
Co-Founder and Executive Chair
2020-11-01
Aron Knickerbocker Chief Executive Officer @ Aulos Bioscience
Chief Executive Officer
2021-03-01
Yanay Ofran Co-Founder and CSO @ Aulos Bioscience
Co-Founder and CSO
2020-12-01
Founder
Investors List
Apple Tree Partners
Apple Tree Partners investment in Series A - Aulos Bioscience
Apple Tree Partners
Apple Tree Partners investment in Series A - Aulos Bioscience
Official Site Inspections
http://www.aulosbio.com
- Host name: ec2-3-128-232-116.us-east-2.compute.amazonaws.com
- IP address: 3.128.232.116
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Aulos Bioscience"
About Us - Changemakers in the immuno-oncology - Aulos …
Changemaker status in the immuno-oncology field. Our initial clinical candidate, AU-007, stands distinctly separate from all other current IL-2 therapeutics with a novel approach that we …See details»
Aulos Bioscience - Crunchbase Company Profile & Funding
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Their initial clinical candidate, AU-007, stands apart from …See details»
Mission and Values - Aulos Bioscience
We are a balanced organization that pursues the best ideas. GROWTH. We are committed to grow individually and as a team. HOPE. We aspire to provide hope to patients and their loved ones with novel therapy. SUPPORT. We support …See details»
Aulos Bioscience Company Profile | Management and Employees …
JohnSmith@aulosbio.com: 4: first_last: John_Smith@aulosbio.com: 5: last: Smith@aulosbio.com: Your Questions, Our Answers Get Free Access to Aulos Bioscience Contacts Info. What is …See details»
Aulos Bioscience: Revenue, Worth, Valuation & Competitors 2025
Organization Aulos Bioscience. Location. Larkspur, California, Industry Biotechnology Research. Share On: Overview About Aulos Bioscience Revenue & Valuation Employee Data …See details»
Aulos Bioscience - VentureRadar
"Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Aulos was created by ATP, a leading life science venture …See details»
Aulos Bioscience - LinkedIn
Aulos Bioscience is an immuno-oncology company revolutionizing cancer patient care through best-in-class IL-2 therapeutics computationally designed to exquisitely direct patients’ own immune ...See details»
Aulos Bioscience, Inc. - Drug pipelines, Patents, Clinical trials
For more information, visit www.aulosbio.com , X ( @AulosBioscience ) and LinkedIn . Clinical Result Immunotherapy Phase 2 Phase 1 ASCO. ... The statistics for drugs in the Pipeline is …See details»
Aulos Bioscience - Overview, News & Similar companies - ZoomInfo
Apr 23, 2024 www.aulosbio.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Aulos Bioscience Enters Into Clinical Trial …See details»
Board of Directors - Aulos Bioscience
Over the course of 10 years in that role, his organization developed and obtained regulatory approval for 11 new cancer medicines, including first-in-class medicines Ibrance® (palbociclib) …See details»
Aulos Bioscience Company Profile - Office Locations ... - Craft
Aulos Bioscience has 5 employees at their 1 location and $60 m in total funding,. See insights on Aulos Bioscience including office locations, competitors, revenue, financials, executives, …See details»
Aulos 2025 Company Profile: Valuation, Funding & Investors
Aulos General Information Description. Operator of a biotechnology company designed to exquisitely direct patients' immune systems toward killing tumor cells. The company is …See details»
Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 ...
1 day ago For more information, visit www.aulosbio.com, X (@AulosBioscience) and LinkedIn. info@aulosbio.com Media inquiries: Mike Beyer, Sam Brown Inc. / 312-961-2502 / …See details»
Aulos Bioscience Appoints Aron Knickerbocker as CEO - PR …
Mar 15, 2021 BOSTON and TEL AVIV, Israel, March 15, 2021 /PRNewswire/ -- Aulos Bioscience, a biotechnology company that is developing highly differentiated interleukin-2 (IL …See details»
Recommended Stories
6 hours ago LARKSPUR, Calif., March 25, 2025--Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class …See details»
Corporate Presentation | Aulos Bioscience
Aulos bioscience 700 larkspur landing circle suite 108 larkspur, ca 94939See details»
Aulos Bioscience to Present Promising Phase 2 Data for Novel
5 hours ago LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of potentially best-in-class …See details»
ATP and Biolojic Design Launch Aulos Bioscience to Develop …
Jan 8, 2021 For more information, visit aulosbio.com. MEDIA CONTACTS: ATP: Sally Jacob [email protected] 212-468-5800. Biolojic: Ryo Imai / Robert Flamm, Ph.D. Burns McClellan …See details»
Investors | Aulos Bioscience
Aulos bioscience 700 larkspur landing circle suite 108 larkspur, ca 94939See details»
Aulos Bioscience, Inc. (Aulos Bioscience, Inc.) - 药物管线_专利_临床 …
Contacts Contact: info@aulosbio.com Media inquiries: Mike Beyer, Sam Brown Inc. / 312-961-2502 / mikebeyer@sambrown.com 临床2期 AACR会议 免疫疗法 临床1期 临床结果 100 项与 …See details»